Crossmark

Tocilizumab como posible causa de colitis isquémica

Crossref DOI link: https://doi.org/10.1016/j.gastrohep.2020.07.016

Published Print: 2021-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Forneiro Pérez, Rocío

Dabán López, Pablo

Zurita Saavedra, María Sol

Hernández García, María Dolores

Mirón Pozo, Benito
License Information

Text and Data Mining valid from 2021-05-01
More Information

This article is maintained by: Elsevier

Article Title: Tocilizumab como posible causa de colitis isquémica

Journal Title: Gastroenterología y Hepatología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastrohep.2020.07.016

Content Type: simple-article

Copyright: © 2020 Elsevier España, S.L.U. All rights reserved.